Condition: Blood Donation · Blood Platelets · Blood Donors · Sponsor: Etablissement Français du Sang
"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and biological characteristics of blood products prepared by the EFS vs. the labile blood product prepared by the CTSA.
This description comes directly from the study's public registry record.
Hind HAMZEH-COGNASSE, PhD, HDR · +33 477 421 400 · hind.hamzeh@univ-st-etienne.fr
Fabrice COGNASSE, PhD, HDR · +33 683 975 883 · fabrice.cognasse@efs.sante.fr
Always discuss trial participation with your own doctor first.
| Maison du don de l'EFS Auvergne Rhônes-Alpes | Saint-Etienne, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06809010